文献库搜索 | GeneLibs

Xue(H),Chen(Y),Qi(F),Chen(K),Liu(X),Zhang(... Ther Adv Med Oncol None

...ALK, KRAS) and key non-driver genes (TP53, STK11, KEAP1) in NSCLC metastasis. These mutations influence tumor invasivene...

Puri(S),Sang(J),Pandey(P),Lee(Y) Proc Natl Acad Sci U S A 2026-02-24

...ALK) region, which in turn recruit Lkr-expressing insulin-producing cells (IPCs), also referred to as medial neurosecret...

Gholameipour(M),Khosravinia(H),Masouri(B) Poult Sci 2026-05-00

...ALK activity showed a weak and a moderate correlation coefficient with tibia ash percentage, respectively. No significan...

Anjum(MN),Nadeem(S),Al-Amin(M),Saalim(M),S... Comput Biol Chem 2026-08-00

...ALK) tyrosine kinase inhibitors. An initial library of 3546 compounds from the CHEMBL4247 database was systematically fi...

Fedyanin(M),Zhukov(N),Moiseenko(F),Mironen... Crit Rev Oncol Hematol 2026-05-00

...ALK alterations. This study aimed to compare overall (OS) and progression-free (PFS) survival among anti-PD-1/PD-L1-cont...

Varty(K),MacLean(L),Itani(D),Hossain(M),Ac... Genes Chromosomes Cancer 2026-02-00

...ALK, EGFR, FGFR2, FGFR3, MYC, NF1, NRAS, and PIK3CA, with potential effects on MAPK/ERK and PI3K/AKT signaling. This coh...

Jafari(A),Fathi(S),Moosavi(F),Firuzi(O) Biochim Biophys Acta Rev Ca... 2026-07-00

...ALK, FGFR, IGF1R, and PDGFRs, among others. Preclinical studies demonstrate synergistic effects in multiple cancer types...

Akın(AE),Durmaz(CD),Yılmaz(AN),Akcin(OC),K... Virchows Arch 2026-07-00

...ALK expression (negative for clone 5A4 and positive for clone ALK1), negative ALK rearrangement by FISH, and the presenc...

Verma(KK),Bugalia(A),Behera(AK),Hussain(N) Cureus 2026-01-00

...ALK), and c-ros oncogene 1 (ROS1) expression in lung adenocarcinoma (ADC). Methods Sixty-two cases were analyzed for ALK...

Kanno(C),Takahashi(S),Hagiwara(M),Furumoto... JTO Clin Res Rep 2026-03-00

...ALK gene rearrangement. Treatment with alectinib led to rapid clinical improvement and sustained disease control for mor...